The Indian pharmaceuticals industry is widely regarded as 'the pharmacy to the world'. Indian Pharma companies meet 20% of the global demand for ...
Read more: Gujarat Themis: Growth at Low Value?
Friday, October 30, 2020
Pharma Reviews: The challenges and opportunities of innovating in India
Today, we are an innovation-led global biopharmaceuticals company that is catering to the unmet global need for affordable life-saving medicines.
Read more: The challenges and opportunities of innovating in India
Read more: The challenges and opportunities of innovating in India
Pharma Reviews: Govt expands PLI scheme: India seeks to cull China reliance with latest move to boost bulk drug ...
Key Highlights. India's pharma industry is, reportedly, the 3rd largest in the world by volume, and the 14th largest in terms of value; Indian ...
Read more: Govt expands PLI scheme: India seeks to cull China reliance with latest move to boost bulk drug ...
Read more: Govt expands PLI scheme: India seeks to cull China reliance with latest move to boost bulk drug ...
US FDA News: FDA, Homeland Security Agencies Take Additional Action to Prevent Import of Illegal and Harmful Medical Products Through International Mail Facilities
Leadership from the U.S. Food and Drug Administration, the U.S. Customs and Border Protection (CBP), and the U.S. Immigration and Customs Enforcement, Homeland Security Investigations (ICE-HSI) signed a Memorandum of Understanding (MOU) to stop harmful products that pose a threat to public health an
Read more: FDA, Homeland Security Agencies Take Additional Action to Prevent Import of Illegal and Harmful Medical Products Through International Mail Facilities
Read more: FDA, Homeland Security Agencies Take Additional Action to Prevent Import of Illegal and Harmful Medical Products Through International Mail Facilities
US FDA News: FDA Publishes List of Essential Medicines, Medical Countermeasures, Critical Inputs Required by Executive Order
A recent executive order directed FDA, in consultation with federal partners, to identify a list of essential medicines, medical countermeasures and critical inputs that are medically necessary to have available at all times in an amount adequate to serve patient needs.
Read more: FDA Publishes List of Essential Medicines, Medical Countermeasures, Critical Inputs Required by Executive Order
Read more: FDA Publishes List of Essential Medicines, Medical Countermeasures, Critical Inputs Required by Executive Order
Thursday, October 29, 2020
US FDA News: Baxter Issues Urgent Device Correction to Reinforce Important Safety Information Regarding Cleaning Practices of all Sigma Spectrum Infusion Pumps (V6, V8 and IQ)
Baxter International Inc. announced today it has issued an Urgent Device Correction to reinforce important safety information regarding cleaning practices of all Spectrum infusion pumps distributed in the United States, Canada, and the Caribbean, as deviations from the specified cleaning methods may
Read more: Baxter Issues Urgent Device Correction to Reinforce Important Safety Information Regarding Cleaning Practices of all Sigma Spectrum Infusion Pumps (V6, V8 and IQ)
Read more: Baxter Issues Urgent Device Correction to Reinforce Important Safety Information Regarding Cleaning Practices of all Sigma Spectrum Infusion Pumps (V6, V8 and IQ)
Pharma Reviews: Pharma data breaches should stop once data protection law comes into force
Three major cyber attacks in the Indian pharma industry in the last few months have left people wondering whether there is a pattern indicating the ...
Read more: Pharma data breaches should stop once data protection law comes into force
Read more: Pharma data breaches should stop once data protection law comes into force
Pharma Reviews: Coronavirus live updates: Nearly 11 lakh tests performed every day for past 6 weeks
India's confirmed coronavirus toll has crossed 80 lakh-mark with daily cases ... India performs 1 crore Covid-19 tests in last 9 days, consistent dip in ... of an FIR by CBI against ten Indian pharmaceutical firms for manufacturing and ...
Read more: Coronavirus live updates: Nearly 11 lakh tests performed every day for past 6 weeks
Read more: Coronavirus live updates: Nearly 11 lakh tests performed every day for past 6 weeks
Pharma Reviews: Stock Market Live: Sensex, Nifty trade lower; L&T, Titan major index losers, slip over 4%
Stock Market Live: The Indian stock market opened on a negative note on ... Stock Update: Ajanta Pharma's gained as much as over 5 percent to Rs ...
Read more: Stock Market Live: Sensex, Nifty trade lower; L&T, Titan major index losers, slip over 4%
Read more: Stock Market Live: Sensex, Nifty trade lower; L&T, Titan major index losers, slip over 4%
Wednesday, October 28, 2020
Pharma Reviews: Diwali Stock Picks 2020: APL Apollo Tubes, Alembic Pharma, Airtel to Nestle, 7 stocks to buy to ...
Second pick is Alembic Pharma, the market cap of the company is Rs 18,853, at the ... Importantly, the Indian market has only two strong players viz.
Read more: Diwali Stock Picks 2020: APL Apollo Tubes, Alembic Pharma, Airtel to Nestle, 7 stocks to buy to ...
Read more: Diwali Stock Picks 2020: APL Apollo Tubes, Alembic Pharma, Airtel to Nestle, 7 stocks to buy to ...
US FDA News: Sunstar Americas Inc. Issues Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% Due to Microbial Contamination
Sunstar Americas, Inc. (SAI) is voluntarily recalling Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 6/30/22 – 9/30/22 (see specific lots below) to the consumer level. This product may be contaminated with
the bacteria Burkholderia lata.
Read more: Sunstar Americas Inc. Issues Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% Due to Microbial Contamination
the bacteria Burkholderia lata.
Read more: Sunstar Americas Inc. Issues Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% Due to Microbial Contamination
Tuesday, October 27, 2020
Pharma Reviews: The strange, listless response of Sun Pharma, India's largest drugmaker, to Covid-19
Sun Pharma's Covid-19 efforts, however, have been overshadowed by its rivals. The company doesn't figure in the list of companies that got licences ...
Read more: The strange, listless response of Sun Pharma, India's largest drugmaker, to Covid-19
Read more: The strange, listless response of Sun Pharma, India's largest drugmaker, to Covid-19
Pharma Reviews: Australia and India: Capturing the opportunities in life sciences
India's pharmaceutical strength can be understood from the huge presence of over 3,000 pharma companies, with over 10,000 manufacturing facilities ...
Read more: Australia and India: Capturing the opportunities in life sciences
Read more: Australia and India: Capturing the opportunities in life sciences
US FDA News: FDA Approves Lotion for Nonprescription Use to Treat Head Lice
The FDA has approved a lotion to treat head lice for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch.
Read more: FDA Approves Lotion for Nonprescription Use to Treat Head Lice
Read more: FDA Approves Lotion for Nonprescription Use to Treat Head Lice
Product Recall Alerts: Metformin Recall Expanded
Marksans Pharma Limited of India has expanded its recall from June 5, 2020 ... website (https://ift.tt/2HwLrnDrecalls-market-withdrawals-safety-alerts/ ... If your medication is on the recall list, contact the doctor who prescribed it ...
Read more: Metformin Recall Expanded
Read more: Metformin Recall Expanded
Pharma Reviews: Granules India, Laurus Labs to set up Greenfield facilities separately in Telangana-Govt
The company already operates the world's largest Commercial Pharmaceutical Formulation Intermediates (PFI) Facility at nearby Gagillapur. Krishna ...
Read more: Granules India, Laurus Labs to set up Greenfield facilities separately in Telangana-Govt
Read more: Granules India, Laurus Labs to set up Greenfield facilities separately in Telangana-Govt
Pharma Reviews: Stock Market Live: Sensex jumps over 300 points, Nifty above 11850; banks, auto stocks fuel rally
Stock Market Live: Indian indices were trading higher on Tuesday afternoon led by heavy buying in banking, auto, FMCG, pharma and media stocks.
Read more: Stock Market Live: Sensex jumps over 300 points, Nifty above 11850; banks, auto stocks fuel rally
Read more: Stock Market Live: Sensex jumps over 300 points, Nifty above 11850; banks, auto stocks fuel rally
Monday, October 26, 2020
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup October 26, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 26, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 26, 2020
Pharma Reviews: Cadila Pharma, ISCR focus on innovation via pharmacoeconomics
Cadila Pharmaceuticals in association with the Indian Society for Clinical ... “Pricing of drugs is an important factor for any country's pharmaceutical ...
Read more: Cadila Pharma, ISCR focus on innovation via pharmacoeconomics
Read more: Cadila Pharma, ISCR focus on innovation via pharmacoeconomics
Friday, October 23, 2020
Pharma Reviews: Post data breach at Dr Reddy's, firms urged to combat cybercrime
Rachamalla also urged companies to vet their staff so that the probability of human ... perpetrated on devices originating from the pharmaceutical industry. The report stated that India ranked sixth in the highest number of devices ...
Read more: Post data breach at Dr Reddy's, firms urged to combat cybercrime
Read more: Post data breach at Dr Reddy's, firms urged to combat cybercrime
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup October 23, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 23, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 23, 2020
Pharma Reviews: Zydus Cadila receives final approval from USFDA for Albuterol Tablets
Zydus Cadila has received final approval from the USFDA to market ... The drug will be manufactured at the group's formulation manufacturing facility at ... US market, it is good for Indian pharmaceutical industry to find place in export.
Read more: Zydus Cadila receives final approval from USFDA for Albuterol Tablets
Read more: Zydus Cadila receives final approval from USFDA for Albuterol Tablets
Pharma Reviews: CDSCO says Covid vaccine Sputnik V to be tested on 100 Indian volunteers
DCGI has granted permission to pharmaceutical giant Dr Reddy's Laboratories for conducting tests. However, the date and time of the test will be ...
Read more: CDSCO says Covid vaccine Sputnik V to be tested on 100 Indian volunteers
Read more: CDSCO says Covid vaccine Sputnik V to be tested on 100 Indian volunteers
Thursday, October 22, 2020
Pharma Reviews: Don't let one-off events deter you, pharma remains a great buy
I am still quite positive on pharmaceutical stocks and I do think that ... Indian pharma companies themselves have done a lot of strategising over the ...
Read more: Don't let one-off events deter you, pharma remains a great buy
Read more: Don't let one-off events deter you, pharma remains a great buy
Pharma Reviews: Dr Reddy's isolates data centre services after cyber attack
An executive at an Indian pharma company said on condition of anonymity: “Over the last 10-15 years, pharmaceutical companies have shifted most of ...
Read more: Dr Reddy's isolates data centre services after cyber attack
Read more: Dr Reddy's isolates data centre services after cyber attack
US FDA News: FDA Approves First Treatment for COVID-19
FDA approved the antiviral drug Veklury (remdesivir) for adults and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization. Veklury is the first treatment for COVID-19 to receive FDA approval.
Read more: FDA Approves First Treatment for COVID-19
Read more: FDA Approves First Treatment for COVID-19
Wednesday, October 21, 2020
Pharma Reviews: Market LIVE: Sensex down 200 pts, Nifty below 11900; IndusInd Bank falls most
Aurobindo Pharma down over 5%; subsidiary gets warning letter ... at a webinar organized by industry lobby Confederation of Indian Industry, or CII.
Read more: Market LIVE: Sensex down 200 pts, Nifty below 11900; IndusInd Bank falls most
Read more: Market LIVE: Sensex down 200 pts, Nifty below 11900; IndusInd Bank falls most
Pharma Reviews: Moneycontrol Daily: Your Essential 7
Gland Pharma, which is majorly owned by China's Shanghai Fosun ... drug maker fructify, it would mark the first major IPO by an Indian company that ...
Read more: Moneycontrol Daily: Your Essential 7
Read more: Moneycontrol Daily: Your Essential 7
Pharma Reviews: Trade hit by record 60% surge in freight
“Both air and sea freight have gone up over the last few months, which may have an impact on companies,” Indian Drug Manufacturers' Association ...
Read more: Trade hit by record 60% surge in freight
Read more: Trade hit by record 60% surge in freight
Pharma Reviews: Chinese Exporters To Suffer ₹40000 Cr Diwali Season Amid Boycott Call By Domestic ...
While china has a strong pharmaceuticals industry it still isn't as good as India's. We Indians love gems and jewels but we are not the only one with this ...
Read more: Chinese Exporters To Suffer ₹40000 Cr Diwali Season Amid Boycott Call By Domestic ...
Read more: Chinese Exporters To Suffer ₹40000 Cr Diwali Season Amid Boycott Call By Domestic ...
Pharma Reviews: India has $25 billion cannabis business in next 5 years
There is a huge demand for cannabis in the global market for its medicinal value and industrial usage. According to a report by Grand View Research Inc ...
Read more: India has $25 billion cannabis business in next 5 years
Read more: India has $25 billion cannabis business in next 5 years
Pharma Reviews: BDR Pharma launches generic cancer drug in India
BDR Pharmaceuticals on Wednesday said it has launched the generic version of Lenvatinib drug for the treatment of various types of cancers in India.
Read more: BDR Pharma launches generic cancer drug in India
Read more: BDR Pharma launches generic cancer drug in India
Tuesday, October 20, 2020
Pharma Reviews: Delays in customs clearance crippling India's import-export industry
Customs clearance delays continue to cripple the Indian industry as they have ... Sharad Kumar Saraf, President of the Federation of Indian Export ... F&B, food processing industry, clothing, leather, pharma, medical equipment and ...
Read more: Delays in customs clearance crippling India's import-export industry
Read more: Delays in customs clearance crippling India's import-export industry
Pharma Reviews: COVID-19 vaccine delivery: Prepping for challenge extraordinaire
DHL opened its first temperature-controlled facility in India in July near the Hyderabad airport for pharma shipments. The company informed that the ...
Read more: COVID-19 vaccine delivery: Prepping for challenge extraordinaire
Read more: COVID-19 vaccine delivery: Prepping for challenge extraordinaire
Pharma Reviews: UAE Envoy, General Bipin Rawat Discuss Defence Cooperation Over Phone Call
Indian pharmaceutical sector plays vital role. Kapoor said that the world has been witness to the “vital role” played by the Indian pharmaceutical sector in ...
Read more: UAE Envoy, General Bipin Rawat Discuss Defence Cooperation Over Phone Call
Read more: UAE Envoy, General Bipin Rawat Discuss Defence Cooperation Over Phone Call
Pharma Reviews: When moisture is torture: Environment control solutions to the rescue in our daily lives
World over the labs, the pharma companies and the hospitals rely on the ... of the Indian pharma sector on China for its API (Active Pharmaceutical ...
Read more: When moisture is torture: Environment control solutions to the rescue in our daily lives
Read more: When moisture is torture: Environment control solutions to the rescue in our daily lives
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup October 20, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 20, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 20, 2020
Pharma Reviews: Explained: Why engineering graduates should look beyond IT firms as a career?
As per industry estimates, only 2.5 lakh engineering graduates land relevant ... Since it caters to customers globally, Indian pharma companies are the ...
Read more: Explained: Why engineering graduates should look beyond IT firms as a career?
Read more: Explained: Why engineering graduates should look beyond IT firms as a career?
Pharma Reviews: Mankind Pharma, RDIF ink pact for Sputnik V sale in India
New Delhi: The Covid-19 vaccine, Sputnik V is now likely to be rolled out in India by Delhi-based Mankind Pharma apart from Dr Reddy's Laboratories ...
Read more: Mankind Pharma, RDIF ink pact for Sputnik V sale in India
Read more: Mankind Pharma, RDIF ink pact for Sputnik V sale in India
Pharma Reviews: Closing Bell: Nifty ends near 11900, Sensex up 112 pts led by IT stocks
Market Close: Indian indices rose for the third straight session on October 20 ... On the sectoral front, IT index gained 1 percent followed by the pharma and ... The initial security and DOME deployments will focus on IoT, industrial, ...
Read more: Closing Bell: Nifty ends near 11900, Sensex up 112 pts led by IT stocks
Read more: Closing Bell: Nifty ends near 11900, Sensex up 112 pts led by IT stocks
Monday, October 19, 2020
Pharma Reviews: COVID-19 will mark an era of a paradigm shift in the realm of diplomacy with healthcare medical ...
“We have great cooperation with India, and we look forward to supporting any Indian pharma or medical industry to invest with us,” HE Dr Amiri said.
Read more: COVID-19 will mark an era of a paradigm shift in the realm of diplomacy with healthcare medical ...
Read more: COVID-19 will mark an era of a paradigm shift in the realm of diplomacy with healthcare medical ...
Pharma Reviews: UAE to provide incentives to Indian healthcare firms with strong R&D facilities: Envoy
... shown a strong desire for setting up manufacturing facilities for vaccines and generic medicines by Indian companies having strong R&D facilities.
Read more: UAE to provide incentives to Indian healthcare firms with strong R&D facilities: Envoy
Read more: UAE to provide incentives to Indian healthcare firms with strong R&D facilities: Envoy
Pharma Reviews: A New Prescription: How COVID-19 Has Changed Indian Pharma
In the bonfire of disruptions across India Inc, triggered by the pandemic, the lattice of the pharmaceutical industry can hardly escape the embers.
Read more: A New Prescription: How COVID-19 Has Changed Indian Pharma
Read more: A New Prescription: How COVID-19 Has Changed Indian Pharma
Pharma Reviews: Sensex, Nifty end higher buoyed by gains in banks, financials, FMCG stocks
Pharma, IT, media, and auto stocks were, however, under pressure. ... The Indian government has asked at least eight state-run companies to ...
Read more: Sensex, Nifty end higher buoyed by gains in banks, financials, FMCG stocks
Read more: Sensex, Nifty end higher buoyed by gains in banks, financials, FMCG stocks
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup October 19, 2020
Coronavirus (COVID-19) Update: Daily Roundup of FDA Actions, October 19, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 19, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 19, 2020
Saturday, October 17, 2020
Pharma Reviews: The Untold Story of the Left in Indian Science
When the British left India, the pharmaceutical industry was completely in the hands of British capital, which produced active pharmaceutical ingredient ...
Read more: The Untold Story of the Left in Indian Science
Read more: The Untold Story of the Left in Indian Science
Pharma Reviews: Remdesivir, HCQ don't aid much in recovery of Covid-19 patients: WHO trials
Listed pharmaceutical companies that manufacture remdesivir in India ... Senior officials in Indian pharma firms that have licensing agreements with ...
Read more: Remdesivir, HCQ don't aid much in recovery of Covid-19 patients: WHO trials
Read more: Remdesivir, HCQ don't aid much in recovery of Covid-19 patients: WHO trials
Friday, October 16, 2020
Pharma Reviews: Govt invites Latin American, Caribbean nations to invest in Indian Pharma Sector
"We are confident that the Indian pharma sector can grow to USD 65 billion industry by 2024," Gowda said. New Delhi: Chemicals and Fertilisers ...
Read more: Govt invites Latin American, Caribbean nations to invest in Indian Pharma Sector
Read more: Govt invites Latin American, Caribbean nations to invest in Indian Pharma Sector
Pharma Reviews: Closing Bell: Nifty ends above 11750, Sensex gains 254 pts led by metal, bank stocks
Cement, metals and pharmaceutical stocks performed well in the broader market. ... Risk could be resurgence of Covid-19 in India. October 16, 2020 ...
Read more: Closing Bell: Nifty ends above 11750, Sensex gains 254 pts led by metal, bank stocks
Read more: Closing Bell: Nifty ends above 11750, Sensex gains 254 pts led by metal, bank stocks
Pharma Reviews: Indian pharma sector can grow to 65 billion dollar industry by 2024: Sadananda Gowda
Chemicals and Fertilizers Minister DV Sadananda Gowda said India is one of the largest manufacturers and exporters of generic medicines across the ...
Read more: Indian pharma sector can grow to 65 billion dollar industry by 2024: Sadananda Gowda
Read more: Indian pharma sector can grow to 65 billion dollar industry by 2024: Sadananda Gowda
Pharma Reviews: Issar Pharma develops first-ever peptide molecule for skin care
... in 1995 with the only aim to work in the area of peptide-based drugs when Peptide Technology was starting to find its feet in Indian Pharma Industry.
Read more: Issar Pharma develops first-ever peptide molecule for skin care
Read more: Issar Pharma develops first-ever peptide molecule for skin care
Pharma Reviews: Natco Pharma eyes launch of 8-10 new drugs in India yearly
Hyderabad: Natco Pharma aims to launch around 10 new products every year in the Indian market, the city-based drug maker said on Thursday.
Read more: Natco Pharma eyes launch of 8-10 new drugs in India yearly
Read more: Natco Pharma eyes launch of 8-10 new drugs in India yearly
Pharma Reviews: Govt calls for investment in Indian pharma sector
India is one of the largest manufacturers and exporters of generic medicines across the world: DV Sadananda Gowda. Image credit- PIB.
Read more: Govt calls for investment in Indian pharma sector
Read more: Govt calls for investment in Indian pharma sector
Pharma Reviews: 'India leading manufacturers, exporters of generic medicines'
'India leading manufacturers, exporters of generic medicines' ... Shri Gowda said that Indian pharma sector can grow to $ 65 billion industry by 2024.
Read more: 'India leading manufacturers, exporters of generic medicines'
Read more: 'India leading manufacturers, exporters of generic medicines'
Pharma Reviews: India is one of the largest manufacturers and exporters of generic medicines across the world: Shri ...
Referring to India supplying these medicines to more than 120 countries ... said that Indian pharma sector can grow to $ 65 billion industry by 2024.
Read more: India is one of the largest manufacturers and exporters of generic medicines across the world: Shri ...
Read more: India is one of the largest manufacturers and exporters of generic medicines across the world: Shri ...
Thursday, October 15, 2020
US FDA News: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Drug Safety Communication - Avoid Use of NSAIDs in Pregnancy at 20 Weeks or Later
FDA is warning that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby. This can lead to low levels of amniotic fluid surrounding the baby and possible complications.
Read more: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Drug Safety Communication - Avoid Use of NSAIDs in Pregnancy at 20 Weeks or Later
Read more: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Drug Safety Communication - Avoid Use of NSAIDs in Pregnancy at 20 Weeks or Later
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup October 15, 2020
The FDA re-issues Emergency Use Authorization for certain filtering facepiece respirators.
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 15, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 15, 2020
US FDA News: FDA Reissues Emergency Use Authorization for Certain Non-NIOSH-Approved Filtering Face-Piece Respirators Manufactured in China
The FDA reissued the Emergency Use Authorization (EUA) for certain filtering face-piece respirators (FFRs) that are manufactured in China and are not approved by the Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH).
Read more: FDA Reissues Emergency Use Authorization for Certain Non-NIOSH-Approved Filtering Face-Piece Respirators Manufactured in China
Read more: FDA Reissues Emergency Use Authorization for Certain Non-NIOSH-Approved Filtering Face-Piece Respirators Manufactured in China
US FDA News: FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications
Today, FDA issued a Drug Safety Communication announcing label changes that limit the use of pain-relieving and fever-reducing nonsteroidal anti-inflammatory drugs (NSAIDs) after around 20 weeks gestation or later in pregnancy.
Read more: FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications
Read more: FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications
Pharma Reviews: Why India Needs To Secure Chinese Investments Despite Flaring Dispute At The Undemarcated ...
Sources in Indian Pharmaceutical Alliance have indicated that almost 70% of critical pharma ingredients in the country are dependent on Chinese ...
Read more: Why India Needs To Secure Chinese Investments Despite Flaring Dispute At The Undemarcated ...
Read more: Why India Needs To Secure Chinese Investments Despite Flaring Dispute At The Undemarcated ...
Pharma Reviews: Indian pharma sector can grow to $ 65 billion industry by 2024: Sadananda Gowda
Chemicals and Fertilisers Minister D V Sadananda Gowda has said India is one of the largest manufacturers and exporters of generic medicines ...
Read more: Indian pharma sector can grow to $ 65 billion industry by 2024: Sadananda Gowda
Read more: Indian pharma sector can grow to $ 65 billion industry by 2024: Sadananda Gowda
Pharma Reviews: Good time to invest in India and setup manufacturing base in Indian pharma sector – DV ...
He said that India is largest supplier of generic medicines in the world. “India is the only country with largest number of US-FDA compliant Pharma plants ...
Read more: Good time to invest in India and setup manufacturing base in Indian pharma sector – DV ...
Read more: Good time to invest in India and setup manufacturing base in Indian pharma sector – DV ...
Pharma Reviews: Govt invites LatAm, Caribbean nations to invest in India's pharma sector
"We are confident that the Indian pharma sector can grow to USD 65 billion industry by 2024," Gowda said. The government has recently launched ...
Read more: Govt invites LatAm, Caribbean nations to invest in India's pharma sector
Read more: Govt invites LatAm, Caribbean nations to invest in India's pharma sector
Pharma Reviews: The pharma king of the world, India
... video analysis by Mr. Deepak Pahwa, MD, Bry-Air, Asia and J Jayaseelan Chairman, Indian Pharma Association on the the Indian pharma industry.
Read more: The pharma king of the world, India
Read more: The pharma king of the world, India
Pharma Reviews: Indian pharma explores virtual inspections post COVID-19
The Indian pharmaceutical industry had entreated the FDA to conduct "desk reviews" or virtual facility inspections of their facilities. Unlike the physical ...
Read more: Indian pharma explores virtual inspections post COVID-19
Read more: Indian pharma explores virtual inspections post COVID-19
Product Recall Alerts: This Commonly Prescribed Drug Has Just Been Recalled
The alert was issued by the U.S. Food and Drug Administration (FDA) relating to Indian pharmaceutical company Marksans Pharma Limited on the ...
Read more: This Commonly Prescribed Drug Has Just Been Recalled
Read more: This Commonly Prescribed Drug Has Just Been Recalled
Tuesday, October 13, 2020
Pharma Reviews: Innovation – The next frontier
While Indian companies in the last couple of decades have made remarkable progress in manufacturing generic pharma products, none of the ...
Read more: Innovation – The next frontier
Read more: Innovation – The next frontier
Monday, October 12, 2020
Product Recall Alerts: Recall alert: Manufacturers expand diabetes drug recall over excess cancer-causing compound ...
According to CNN, the recall applies to the following products, which can be identified by their National Drug Code numbers listed alongside the ...
Read more: Recall alert: Manufacturers expand diabetes drug recall over excess cancer-causing compound ...
Read more: Recall alert: Manufacturers expand diabetes drug recall over excess cancer-causing compound ...
Product Recall Alerts: Recall alert: Diabetes drug recalled over excess levels of cancer-causing compound
Marksans Pharma Ltd. and Sun Pharmaceutical Industries Ltd., both based in India, joined at least eight other companies in voluntarily recalling ...
Read more: Recall alert: Diabetes drug recalled over excess levels of cancer-causing compound
Read more: Recall alert: Diabetes drug recalled over excess levels of cancer-causing compound
Pharma Reviews: PE firm PAG-led group to buy pharma firm Anjan Drug for undisclosed sum
Srivastava further said, “We see the Indian API market as a very attractive opportunity and well positioned for the future. Globally, this sector is currently ...
Read more: PE firm PAG-led group to buy pharma firm Anjan Drug for undisclosed sum
Read more: PE firm PAG-led group to buy pharma firm Anjan Drug for undisclosed sum
Saturday, October 10, 2020
Pharma Reviews: India and US on cusp of rescuing world from Covid-19
While President Bill Clinton sought to gut the Indian pharmaceutical industry on behalf of Big Pharma, it was President George W. Bush who actually ...
Read more: India and US on cusp of rescuing world from Covid-19
Read more: India and US on cusp of rescuing world from Covid-19
Pharma Reviews: More than APIs, Indian pharma industry needs to reduce dependency on drug intermediates ...
He added that to grow as well as remain competitive in the global pharma market, the industry needs to focus on formulating strategies from the long ...
Read more: More than APIs, Indian pharma industry needs to reduce dependency on drug intermediates ...
Read more: More than APIs, Indian pharma industry needs to reduce dependency on drug intermediates ...
Friday, October 9, 2020
Product Recall Alerts: Recall expands of diabetes drug that may contain cancer-causing agent
The full list of recalled lots can be found on the FDA website. The lot number of your medication is on the side panel of bottle labels, as well as shipper/ ...
Read more: Recall expands of diabetes drug that may contain cancer-causing agent
Read more: Recall expands of diabetes drug that may contain cancer-causing agent
Pharma Reviews: PM Modi Commends IFS Officers For Services To The Nation
During the pandemic, Indian pharma industry emerged as an asset not only for ... India as the pharmacy to the world provided medicines and Covid-19 ...
Read more: PM Modi Commends IFS Officers For Services To The Nation
Read more: PM Modi Commends IFS Officers For Services To The Nation
Pharma Reviews: Madras HC Constitutes Committee To Boost Indian Pharma Sector; Raises Concern Over Heavy ...
"India has emerged as a pioneer in pharmaceuticals. Yet, for the basic ingredients of medicine making, it is heavily dependent on imports from one ...
Read more: Madras HC Constitutes Committee To Boost Indian Pharma Sector; Raises Concern Over Heavy ...
Read more: Madras HC Constitutes Committee To Boost Indian Pharma Sector; Raises Concern Over Heavy ...
Pharma Reviews: CLSA Maintains Buy Rating on Sun Pharma, Cadila Healthcare, Torrent Pharma and Abbott India ...
CLSA thinks pharma sector fundamentals are stronger now than in 2015. A stable U.S. generics market, a strong outlook for India businesses, much ...
Read more: CLSA Maintains Buy Rating on Sun Pharma, Cadila Healthcare, Torrent Pharma and Abbott India ...
Read more: CLSA Maintains Buy Rating on Sun Pharma, Cadila Healthcare, Torrent Pharma and Abbott India ...
Thursday, October 8, 2020
US FDA News: FDA awards six grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
FDA announced awards for six new clinical trial research grants totaling over $16 million over the next four years. The grants, awarded through the Congressionally-funded Orphan Products Grants Program, enhance the development of medical products for patients with rare diseases.
Read more: FDA awards six grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
Read more: FDA awards six grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
US FDA News: FDA Reaffirms Commitment to Safety, Security of its Public Health Laboratories
FDA’s mission to protect and promote public health has always relied on a rigorous analysis of the scientific data available and we’re dedicated to ensuring our staff’s safety by continuing to strengthen a culture that prioritizes workplace safety.
Read more: FDA Reaffirms Commitment to Safety, Security of its Public Health Laboratories
Read more: FDA Reaffirms Commitment to Safety, Security of its Public Health Laboratories
Pharma Reviews: Indian dose sites untapped M&A opportunity for foreign CMOs: GlobalData
Only six US, five UK, and three German CMOs own solid dose manufacturing sites in India.” Bradbury continues, “While the Indian pharma industry is ...
Read more: Indian dose sites untapped M&A opportunity for foreign CMOs: GlobalData
Read more: Indian dose sites untapped M&A opportunity for foreign CMOs: GlobalData
Pharma Reviews: Pharma has become the new darling of Private Equity funds
Pharma has become the new darling of Private Equity funds ... for the economy and many of the start-ups and smaller companies get stretched to the hilt. ... The total PE and VC flows into the pharma space overall has been ... In terms of sheer volume of medicines produced, Indian pharma industry ranks ...
Read more: Pharma has become the new darling of Private Equity funds
Read more: Pharma has become the new darling of Private Equity funds
Wednesday, October 7, 2020
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup October 7, 2020
The FDA issues letter to healthcare providers regarding SARS-CoV-2 testing, and a warning letter for failure to comply with regulatory reporting requirements.
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 7, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 7, 2020
US FDA News: FDA Issues Warning Letter to Battelle Memorial Institute, a Manufacturer of an Authorized Decontamination System Used on Respirators
FDA issued a warning letter to Battelle Memorial Institute for failure to comply with regulatory requirements for medical device reporting.
Read more: FDA Issues Warning Letter to Battelle Memorial Institute, a Manufacturer of an Authorized Decontamination System Used on Respirators
Read more: FDA Issues Warning Letter to Battelle Memorial Institute, a Manufacturer of an Authorized Decontamination System Used on Respirators
US FDA News: Recommendations on Providing Clear Instructions to Patients Who Self-Collect an Anterior Nares (Nasal) Sample in a Health Care Setting for SARS-CoV-2 Testing - Letter to Health Care Providers
FDA's recommendations to health care providers on giving instructions to patients who self-collect an anterior nares sample for SARS-CoV-2 testing.
Read more: Recommendations on Providing Clear Instructions to Patients Who Self-Collect an Anterior Nares (Nasal) Sample in a Health Care Setting for SARS-CoV-2 Testing - Letter to Health Care Providers
Read more: Recommendations on Providing Clear Instructions to Patients Who Self-Collect an Anterior Nares (Nasal) Sample in a Health Care Setting for SARS-CoV-2 Testing - Letter to Health Care Providers
Pharma Reviews: Market LIVE: Sensex gains 300 points led by RIL, Titan; Nifty around 11730
This transaction is one of the largest private equity deals in the Indian pharmaceutical sector. It provides Piramal Pharma Ltd (PPL) growth capital that ...
Read more: Market LIVE: Sensex gains 300 points led by RIL, Titan; Nifty around 11730
Read more: Market LIVE: Sensex gains 300 points led by RIL, Titan; Nifty around 11730
Tuesday, October 6, 2020
Pharma Reviews: Betting on pharma? Build a basket of these stocks
The market has been too pessimistic about the banks' prospects. ... I strongly believe that a rerating is happening in Indian pharma and that is going to ...
Read more: Betting on pharma? Build a basket of these stocks
Read more: Betting on pharma? Build a basket of these stocks
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup October 6, 2020
The FDA launches new COVID-19 vaccine webpage and issues guidance with recommendations for vaccine sponsors.
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 6, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 6, 2020
Pharma Reviews: Healthcare achievers honoured at CIMS Cardiology Conference & Awards 2020
AIIMS,New Delhi),FACC, Individual Excellence and promoter of Fit India ... The awards felicitated achievers of industry including winners and winning companies like Bai Jerbai Wadia Hospital for Children, Amree Pharma, Jineka ...
Read more: Healthcare achievers honoured at CIMS Cardiology Conference & Awards 2020
Read more: Healthcare achievers honoured at CIMS Cardiology Conference & Awards 2020
Pharma Reviews: Motilal Oswal: Divi's Labs - On A Strong Growth Trajectory
Divi's Laboratories Ltd., an Indian pharma company, is among the top three Active Pharmaceutical Ingredient manufacturers in the world. It is also into ...
Read more: Motilal Oswal: Divi's Labs - On A Strong Growth Trajectory
Read more: Motilal Oswal: Divi's Labs - On A Strong Growth Trajectory
Monday, October 5, 2020
Pharma Reviews: AI, blockchain, cryptography driving anti-counterfeit tech in pharma industry
Ennoventure has taken a conscious decision to focus on Indian market as India is the global leader when it comes to export of generic drugs.
Read more: AI, blockchain, cryptography driving anti-counterfeit tech in pharma industry
Read more: AI, blockchain, cryptography driving anti-counterfeit tech in pharma industry
Pharma Reviews: LANXESS India wins awards from Indian Chemical Council
All the vehicles contracted with the company are GPS tracked and violations, if any, are recorded and corrective actions are taken including driver ...
Read more: LANXESS India wins awards from Indian Chemical Council
Read more: LANXESS India wins awards from Indian Chemical Council
Pharma Reviews: Closing Bell: Nifty ends above 11500, Sensex up 276 pts after trading higher through the day; IT ...
The news reports that the US President is recovering well, aided market ... becoming the first Indian and the third Asian pharmaceutical company to ...
Read more: Closing Bell: Nifty ends above 11500, Sensex up 276 pts after trading higher through the day; IT ...
Read more: Closing Bell: Nifty ends above 11500, Sensex up 276 pts after trading higher through the day; IT ...
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup October 5, 2020
Coronavirus (COVID-19) Update: Daily Roundup for October 5, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 5, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 5, 2020
US FDA News: FDA, Mexican Counterparts Enhance Food Safety Partnership
Today, the FDA and its regulatory counterparts in Mexico enhanced a partnership to broaden and strengthen the scope of their existing partnership to include the safety of all human food regulated by the FDA.
Read more: FDA, Mexican Counterparts Enhance Food Safety Partnership
Read more: FDA, Mexican Counterparts Enhance Food Safety Partnership
US FDA News: Marksans Pharma Limited Issues Expansion of Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
Marksans Pharma Limited, India is voluntarily expanding its earlier initiated recall on June 05, 2020 to include an additional 76 unexpired lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg, & 750mg to the consumer level. Marksans performed N-Nitrosodimethylamine (NDMA) testing of
Read more: Marksans Pharma Limited Issues Expansion of Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
Read more: Marksans Pharma Limited Issues Expansion of Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
Sunday, October 4, 2020
Pharma Reviews: Hyderabad Pharma City: A toxic cluster in the making
Pollution from pharmaceutical industries is widespread and chronic in various parts of Telangana, especially Patancheru, Jeedimetla, Choutuppal, ...
Read more: Hyderabad Pharma City: A toxic cluster in the making
Read more: Hyderabad Pharma City: A toxic cluster in the making
Saturday, October 3, 2020
Pharma Reviews: Exports rise 5.27 per cent, trade deficit dips as global demand perks up in September
NEW DELHI: India 's exports grew by 5.27 per cent year-on-year in September ... The Indian Pharma sector was also obviously a Covid beneficiary as ...
Read more: Exports rise 5.27 per cent, trade deficit dips as global demand perks up in September
Read more: Exports rise 5.27 per cent, trade deficit dips as global demand perks up in September
Pharma Reviews: BOTTOMLINE: Want a multi-bagger in your portfolio? Here's what to look for
Ajanta Pharma is a Mumbai-based specialty pharma company focused on branded generic sales in India and the emerging markets. ... the US market—but that was not its first port of call, unlike many other Indian pharma companies.
Read more: BOTTOMLINE: Want a multi-bagger in your portfolio? Here's what to look for
Read more: BOTTOMLINE: Want a multi-bagger in your portfolio? Here's what to look for
Pharma Reviews: Exim Bank study highlights priority focus areas, policy initiatives for sectors including pharma
The study titled 'Domestic Constraints for Exports in Select Sectors', analyses the current domestic policy constraints faced by the Indian exporters in ...
Read more: Exim Bank study highlights priority focus areas, policy initiatives for sectors including pharma
Read more: Exim Bank study highlights priority focus areas, policy initiatives for sectors including pharma
Pharma Reviews: Two more probes into Chinese imports begun
... a certain pharmaceutical raw material by Chinese traders, India's Directorate ... raw material based on a petition by two Indian pharma companies.
Read more: Two more probes into Chinese imports begun
Read more: Two more probes into Chinese imports begun
Pharma Reviews: Exports rise 5.27 per cent in September 2020, trade deficit narrows to USD 2.91 billion
The Indian Pharma sector was also obviously a Covid beneficiary as countries stocked up on drugs for their health care sectors. More from Business.
Read more: Exports rise 5.27 per cent in September 2020, trade deficit narrows to USD 2.91 billion
Read more: Exports rise 5.27 per cent in September 2020, trade deficit narrows to USD 2.91 billion
Pharma Reviews: Dr Reddy's Laboratories Seeks DCGI Nod To Conduct Phase III Trials Of Sputnik V Vaccine
Indian pharmaceutical Dr Reddy's Laboratories seeks permission from ... In response to the application submitted by the Indian Pharma giant, the ...
Read more: Dr Reddy's Laboratories Seeks DCGI Nod To Conduct Phase III Trials Of Sputnik V Vaccine
Read more: Dr Reddy's Laboratories Seeks DCGI Nod To Conduct Phase III Trials Of Sputnik V Vaccine
Friday, October 2, 2020
Pharma Reviews: The Mutual Fund Show: Why Pharma And IT Funds Remain Good Investment Options
And there are various initiatives which drives investing growth over there—the insurance sector picking up and also the Indian companies are getting a ...
Read more: The Mutual Fund Show: Why Pharma And IT Funds Remain Good Investment Options
Read more: The Mutual Fund Show: Why Pharma And IT Funds Remain Good Investment Options
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup October 2, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 2, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 2, 2020
US FDA News: Ashtel Studios Issues Voluntary Recall of Licensed Hand Sanitizers Packaged in 0.84 Fluid Ounce Pouches Due to Misbranding Because They Resemble Food and Drink Container Pouches
Ashtel Studios has announced a voluntary recall of all lots of licensed hand sanitizer packaged in .84 oz containers resembling food and drink pouches labeled with various children’s characters listed in the table below to the consumer level. The products are being recalled because they are packaged
Read more: Ashtel Studios Issues Voluntary Recall of Licensed Hand Sanitizers Packaged in 0.84 Fluid Ounce Pouches Due to Misbranding Because They Resemble Food and Drink Container Pouches
Read more: Ashtel Studios Issues Voluntary Recall of Licensed Hand Sanitizers Packaged in 0.84 Fluid Ounce Pouches Due to Misbranding Because They Resemble Food and Drink Container Pouches
US FDA News: FDA Approves Drug Combination for Treating Mesothelioma
Today, the FDA approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the first-line treatment of adults with malignant pleural mesothelioma that cannot be removed by surgery.
Read more: FDA Approves Drug Combination for Treating Mesothelioma
Read more: FDA Approves Drug Combination for Treating Mesothelioma
US FDA News: Becton Dickinson CareFusion 303, Inc. Recalls Alaris™ System Pump Module and Pump Module Door Assembly Replacement Kits Due to the Potential for Stuck or Unresponsive Keys
Becton Dickinson CareFusion 303, Inc. Recalls Alaris System Pump Module and Pump Module Door Assembly Replacement Kits Due to the Potential for Stuck or Unresponsive Keys
Read more: Becton Dickinson CareFusion 303, Inc. Recalls Alaris™ System Pump Module and Pump Module Door Assembly Replacement Kits Due to the Potential for Stuck or Unresponsive Keys
Read more: Becton Dickinson CareFusion 303, Inc. Recalls Alaris™ System Pump Module and Pump Module Door Assembly Replacement Kits Due to the Potential for Stuck or Unresponsive Keys
Thursday, October 1, 2020
Pharma Reviews: Top Indian pharma firms to strengthen India-Africa trade relationship: Cadila Pharma
This panel discussion was focussed on how India- Africa trade relationships have been growing over the years, the pharmaceutical sector in Africa ...
Read more: Top Indian pharma firms to strengthen India-Africa trade relationship: Cadila Pharma
Read more: Top Indian pharma firms to strengthen India-Africa trade relationship: Cadila Pharma
Pharma Reviews: Pharma manufacturing across Southern India has strong M&A potential: GlobalData
The pharma manufacturing in the three Southern Indian states of Karnataka, Tamil Nadu and Kerala, and Goa (Western India) has a high merger and ...
Read more: Pharma manufacturing across Southern India has strong M&A potential: GlobalData
Read more: Pharma manufacturing across Southern India has strong M&A potential: GlobalData
Pharma Reviews: Best time to invest in pharma, medical device sector: Gowda
The medical devices industry in India has the potential to grow at 28 per cent per annum to reach USD 50 billion by 2025, Gowda said. The Indian ...
Read more: Best time to invest in pharma, medical device sector: Gowda
Read more: Best time to invest in pharma, medical device sector: Gowda
Pharma Reviews: Hetero launches pack of generic COVID-19 drug favipiravir at Rs 2640
The company had earlier on July 29, launched its generic version of favipiravir in India under the brand name 'Favivir' after getting the nod from the ...
Read more: Hetero launches pack of generic COVID-19 drug favipiravir at Rs 2640
Read more: Hetero launches pack of generic COVID-19 drug favipiravir at Rs 2640
Pharma Reviews: Best time to invest in Pharma, Medical device sector in India; $120 billion industry by 2030
Union minister said, Indian pharma and medical device sector have immense potential to contribute towards making India a 5 trillion-dollar economy ...
Read more: Best time to invest in Pharma, Medical device sector in India; $120 billion industry by 2030
Read more: Best time to invest in Pharma, Medical device sector in India; $120 billion industry by 2030
Pharma Reviews: Global Covid-19 impact on Indian Heparin Market Overview, Opportunities and Forecast by ...
Global Indian Heparin Market Report 2020 by Key Players, Types, Applications ... Cipla Ltd., Emcure Pharmaceuticals Pvt. Ltd., Gland Pharma Limited, ...
Read more: Global Covid-19 impact on Indian Heparin Market Overview, Opportunities and Forecast by ...
Read more: Global Covid-19 impact on Indian Heparin Market Overview, Opportunities and Forecast by ...
Pharma Reviews: US hails India partnership as crucial for global recovery from Covid-19
"American company, Gilead has granted voluntary non-exclusive licensing agreements to Indian pharmaceutical companies to produce a generic form ...
Read more: US hails India partnership as crucial for global recovery from Covid-19
Read more: US hails India partnership as crucial for global recovery from Covid-19
Pharma Reviews: AiMeD unveils figure of the growth rate of Indian medical device industry during Covid-19 pandemic
Rajiv Nath, Forum Coordinator, AiMED on the behalf of the Indian medical device industry was in regular consultation with the Govt & assured ...
Read more: AiMeD unveils figure of the growth rate of Indian medical device industry during Covid-19 pandemic
Read more: AiMeD unveils figure of the growth rate of Indian medical device industry during Covid-19 pandemic
Pharma Reviews: FDA widens US safety inquiry into AstraZeneca coronavirus vaccine - sources
Pharma Manufacturing systems are highly variable with each system ... India and South Africa have allowed AstraZeneca to resume its clinical trials ...
Read more: FDA widens US safety inquiry into AstraZeneca coronavirus vaccine - sources
Read more: FDA widens US safety inquiry into AstraZeneca coronavirus vaccine - sources
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup October 1, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 1, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup October 1, 2020
US FDA News: USDA and FDA Sign Memorandum of Understanding to Enhance Collaboration, Efficiency on U.S. Dairy Exports
USDA and FDA sign MOU to enhance collaboration and efficiency to facilitate the export of milk and milk products from the U.S.
Read more: USDA and FDA Sign Memorandum of Understanding to Enhance Collaboration, Efficiency on U.S. Dairy Exports
Read more: USDA and FDA Sign Memorandum of Understanding to Enhance Collaboration, Efficiency on U.S. Dairy Exports
Pharma Reviews: Infra, tech, experts puts us in strong position to move Covid vaccine: Vivek Arya, MD, Rhenus ...
The Indian market is very fragmented with many small players offering ... The geographical spread of manufacturing units for pharma as well as the ...
Read more: Infra, tech, experts puts us in strong position to move Covid vaccine: Vivek Arya, MD, Rhenus ...
Read more: Infra, tech, experts puts us in strong position to move Covid vaccine: Vivek Arya, MD, Rhenus ...
Pharma Reviews: IIFL Wealth and Hurun India releases IIFL WEALTH HURUN INDIA TOP COVID-19 Pharma ...
Indian healthcare entrepreneurs have found niches, taken bets and built scale to create leading companies while addressing the issues of providing ...
Read more: IIFL Wealth and Hurun India releases IIFL WEALTH HURUN INDIA TOP COVID-19 Pharma ...
Read more: IIFL Wealth and Hurun India releases IIFL WEALTH HURUN INDIA TOP COVID-19 Pharma ...
Pharma Reviews: Trending Today Corona impact on Indian Peptides Market Consumption, Strategy Analysis and ...
... Indian Peptides Market Consumption, Strategy Analysis and Forecast by 2025| Biocon Limited , Sun Pharmaceutical Industries Ltd. , Wockhardt Ltd.
Read more: Trending Today Corona impact on Indian Peptides Market Consumption, Strategy Analysis and ...
Read more: Trending Today Corona impact on Indian Peptides Market Consumption, Strategy Analysis and ...
Pharma Reviews: AiMeD Unveils Figure of Growth Rate of Indian Medical Device Industry During COVID-19 Pandemic
Mr. Rajiv Nath, Forum Coordinator, AiMED on behalf of the Indian Medical Device industry was in regular consultation with the Govt & assured ...
Read more: AiMeD Unveils Figure of Growth Rate of Indian Medical Device Industry During COVID-19 Pandemic
Read more: AiMeD Unveils Figure of Growth Rate of Indian Medical Device Industry During COVID-19 Pandemic
Subscribe to:
Comments (Atom)